Infectious Diseases

William J. Muller, MD, PhD, discusses COVID-19 vaccinations for children and what is on the horizon for a potential RSV vaccine.

We seek to reduce vaccine side effects—but what about the social media-compounded fears of anti-COVID vaccination?

A study examined 4 million posts on social media site in 2021.

Was the spike in pediatric cases during the Delta wave of COVID-19 linked to an increase in severe illness? A report offers some answers.

A look at the way that skin may react to COVID-19 and the vaccine for the disease.

School closures have been the go-to move to prevent the spread of COVID-19, but a report investigates whether the use of strict mitigation can work just as well without the need to disrupt a child’s in-person schooling.

Jessica Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAAN, FAAN, clinical professor of nursing, Baylor University, Dallas, Texas, and Jennifer Sonney, PhD, APRN, PPCNP-BC, FAANP, assistant professor at University of Washington School of Nursing in Seattle, Washington, discussed the results of a survey showing the impact of COVID-19 on the pediatric APRN workforce, and analyzed potential future downstream impacts of APRN burnout and exhaustion.

Moderna has released preliminary date from the company's phase 2/3 trial of the vaccine in children aged younger than 6 years.

Racism important for understanding health care disparities

As we begin to navigate our way through year 3 of the COVID-19 pandemic, it's time to question whether mental and behavioral concerns have been ignored.

Rethinking antibiotic guidelines was the focus of this session at the 43rd National Conference on Pediatric Health Care for pediatric nurse practitioners in Dallas, Texas.

Physicians’ group cites CDC data in letter to lawmakers.

State agencies hope to move affected patients to marketplace.

Official death toll is almost 6 million, but excess deaths indicate far more may have died from COVID than reported

Occupational Safety and Health Administration (OSHA) will do a series of re-inspections over a 3 month period to examine precautions against the disease for health care employees.

An investigation illuminates the differences in the immune response to COVID-19 in children when compared to adults.

Skipping physicians for convenience not the best way for patients to receive care says American Medical Association

Multiple pharmaceutical companies are investigating the application of mRNA technology to develop vaccines that treat and prevent multiple conditions, from influenza to cancer and beyond.

The COVID-19 pandemic has been full of difficult situations for children, from education disruptions to lack of socialization at important developmental stages. It's also left many children without parents or caregivers. What can clinicians do to help these children?

Doctors face increased burnout rates, loss of autonomy and greater financial threats from nonphysician practitioners

The days of blanket mitigation strategies to protect children from COVID-19 are becoming a thing of the past. A model sheds light onto determining when strategies can be relaxed.

A large cohort study offers important data on what factors are frequently tied to severe cases of COVID-19 in the pediatric population.

Stopping some doctors from sharing unsound medical advice has proved challenging. Even defining misinformation has been difficult. And during the pandemic, resistance from some state legislatures is complicating the effort.

The safety of the Pfizer/BioNTech COVID-19 vaccine in pregnant women, for both mother and baby, has been dependent on observation during the rollout. A large population trial provides further support for the vaccine’s safety.